Source: Annual Congress 2010 - COPD: management
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Gertsen, A. Zhuiko, E. Atroshchenko (Minsk, Belarus). Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 4017

Member's Comments

No comment yet.

Related content which might interest you: Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 The heart rate variability in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Comorbidities and management in primary care Year: 2011 The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Exercise heart rate recovery in chronic obstructive pulmonary disease patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011 Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 A study of neuromuscular dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Influence of concomitant chronic heart failure on incorrect evaluation of chronic obstructive pulmonary disease assessment tests Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019